Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jin Tiange capsule for primary osteoporosis
ChiCTR-IPR-16008533Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of jintiange in involutional osteoporosis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Bone mineral density. Started Jan 2016; status: completed.
02
Drugs
jintiange
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on ChiCTR-IPR-16008533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008533.